ISMCO 2019: First International Symposium on Mathematical and Computational Oncology

October 14 – 16, 2019
Lake Tahoe, Nevada, USA
http://www.ismco.net

Important Dates
(All deadlines are at 11:59PM Pacific Daylight Time)

Tutorial and Special Track Proposals February 25, 2019
Tutorial & Special Track Notifications March 1, 2019
Paper Submissions August 10, 2019
Notification of Acceptance August 30, 2019
Final Camera Ready Paper September 20, 2019
Advance Registration September 20, 2019
ISMCO Hotel Reservation September 20, 2019
ISMCO’19 October 14 - 16, 2019

Call for Abstracts, Papers, Tutorials, and Special Tracks

Despite significant advances in the understanding of the principal mechanisms leading to various cancer types, less progress has been made toward developing patient-specific treatments. Advanced mathematical and computational models could play a significant role in examining the most effective patient-specific therapies. There is a pressing need to design and develop mathematical and computational strategies to harness cancer data in an accurate and efficient fashion.

The purpose of the International Symposium on Mathematical and Computational Oncology (ISMCO) is to provide a common interdisciplinary forum for researchers, scientists, engineers and clinical oncologists throughout the world to present and discuss their latest research findings, ideas, developments and applications in mathematical and computational oncology. In particular, ISMCO aspires to enable the forging of stronger relationships among physical sciences, computer science, data science, engineering and oncology with the goal of developing new insights into the pathogenesis and treatment of malignancies.

Authors are invited to submit either an abstract (up to three pages) or paper (up to 14 pages) for potential presentation (oral or poster) and publication in the symposium proceedings. The symposium will consist of invited and contributed presentations dealing with all aspects of mathematical and computational oncology. There will also be keynote presentations, tutorials, special tracks, panel discussions, and a poster session. We also invite work-in-progress papers, demos, experimental studies, open-source developments, and visionary papers. Each submissions accepted for oral or poster presentation will appear in the symposium proceedings to be published by Springer-Verlag in the prestigious Lecture Notes in Computer Science (LNCS) series. All full papers will also be submitted for indexing to PubMed Central. Springer-Verlag is also sponsoring a “best paper award.

Authors of selected abstracts or papers accepted for presentation at ISMCO will also be invited to submit extended versions of their work for expedited review and possible publication in a special research topic on Advances in Mathematical and Computational Oncology in the Frontiers in Physiology (Computational Physiology and Medicine, Systems Biology), Frontiers in Genetics (Cancer Genetics, Systems Biology), Frontiers in Oncology (Cancer Genetics), Frontiers in Molecular Biosciences (Biological Modeling and Simulation), Frontiers in Medicine (Precision Medicine), Frontiers in Applied Mathematics and Statistics (Systems Biology), and Frontiers in Robotics and AI (Computational Intelligence). Authors would have the opportunity to select which of the above journals/sections to submit their paper(s). All papers accepted for publication will receive a 10% discount of publication fees and will appear in a dedicated webpage under the common mathematical and computational oncology research topic.

Steering Committee

* Anastasiadis Panagiotis, Mayo Clinic, USA
* Bebis George, University of Nevada, USA (chair)
* Levy Doron, University of Maryland, College Park, USA
* Rockne Russell, City of Hope, USA
* Schlesner Matthias, German Cancer Research Center, Germany
* Tafti Ahmad, Mayo Clinic, USA
* Vasmatzis George, Mayo Clinic, USA

Program Chairs

* Benos Takis, University of Pittsburgh, USA
* Chen Ken, MD Anderson Cancer Center, USA
* Jahn Katharina, ETH Zurich, Switzerland
* Lima Ernesto, University of Texas at Austin, USA

Keynote Speakers

* Bose Ron, Washington University, USA
* Jackson Trachette, University of Michigan, USA
* Pusztai Lajos, Yale Cancer Center, USA
* Raphael Ben, Princeton University, USA
* Shepherd John,Univ. of Hawaii Cancer Center, USA
* Vasmatzis George, Mayo Clinic, USA

Topics

ISMCO seeks papers describing contributions to the state of the art and practice in mathematical and computational oncology. Topics of interest include all aspects of mathematical and computational oncology including, but not limited, to the following areas:

* Multiscale advanced mathematical and computational models
* Precision medicine and immuno-oncology
* Spatio-temporal tumor modeling and simulation
* Tumor forecasting methods
* Molecular subtyping, survival analysis and prediction
* Novel experimental cultures
* Cancer genomics and proteomics
* Next-generation sequencing and single-cell analysis
* Systems biology and networks
* General cancer computational biology
* Computational methods for anticancer drug development
* Cancer epidemiology, biomarkers and prevention
* Statistical methods and data mining for cancer research
* Deep learning and machine learning for cancer research
* Big data analytics for cancer research
* High performance computing for cancer research
* Data intensive computing for cancer research
* Scalable and high throughput systems for large-scale cancer-data analytics
* Text analytics and natural language processing (NLP) for cancer research
* Automatic semantic annotation of medical content in the context of cancer disease
* Application of cloud computing, SaaS and PaaS architectures for cancer research
* Computer-aided diagnosis (CADx) systems for cancer research
* Computer vision, scientific visualization, and image processing for cancer research
* Robotics for cancer research
* Artificial Intelligence for cancer research
* Special Track: Single-Cell Omics in Cancer
* Special Track: AI meets Social Media: Integrating Artificial Intelligence and Social Media to Advance Cancer Research
* Special Track: Tumor evolvability and intra-tumor heterogeneity
* Special Track: N-of-1 oncology: Developing a ‘personalome’ for precision medicine
* Special Track: Models of Education in Mathematical and Computational Oncology
* Special Track: Inverse problems in imaged-based tumor modeling and prediction

Tutorials and Special Tracks

Proposals are invited for tutorials and special tracks on topics relevant to ISMCO. Tutorials should address the interests of various individuals in the field of mathematical and computational oncology including graduate students, researchers and educators from academia, and researchers and practitioners from industry and government. Special tracks will take place during the main dates of the symposium and are intended to stimulate in-depth discussions in special areas relevant to the symposium theme. All papers accepted for presentation in a special track will be published in the symposium proceedings.
Review Process
Both abstracts and papers submitted to ISMCO must not be currently under consideration for presentation/publication in another conference. Each submission will receive 2-3 blind reviews and should not contain names or other information revealing authors’ identity. Submissions will be reviewed with an emphasis on potential to contribute to the state of the art in the field. Selection criteria include accuracy and originality of ideas, clarity and significance of results, and presentation quality. The form of presentation (oral or poster) will be decided based on the reviews of each submission and recommendation of the program chairs and the steering committee.

Attendance

At least one author of each accepted paper must complete the symposium registration and present the paper at the symposium, in order for their paper to be included in the proceedings and symposium program. If none of the authors cannot attend the symposium and present their paper(s) due to unforeseen reasons, they should make arrangements with another ISMCO attendee to present their paper(s). Video or Skype presentations are not acceptable.